Semax
ACTH (the pituitary signal that tells the adrenals to make cortisol)-fragment cognition-focused peptide — not FDA-approved in the U.S.
What it's for
Semax is a lab-made peptide analog of ACTH (the pituitary signal that tells the adrenals to make cortisol) with a Pro-Gly-Pro extension, developed and used in some countries (notably Russia) for neurologic research and practice contexts.
What it does for the body
It has been studied for cognitive, stroke, and optic-nerve related endpoints in those research settings. It is not FDA-approved in the United States. People often hear about it through clinics, forums, or news — this guide sticks to what published research and regulators actually support.
What it targets
Proposed actions include gentle adjustment of BDNF (a brain growth-support chemical) and other neurotrophic pathways and effects on mood-related brain chemicals systems in animal and limited human research — not a simple stimulant how it works.
Research context
Bottom line for readers: Semax is best treated as a research-interest topic. Early papers can be fascinating; they are not a green light for self-experimentation.
Studied for (literature interest)
- Brain research interest (educational tag)
Cautions (educational)
- Educational only — not medical advice.
- DrPep does not offer medical consultations, dosing guidance, suppliers, or peptide sales.
Citations / starters
- FDA search: Semax — FDA.gov search
- ClinicalTrials.gov search: Semax — U.S. clinical trials registry
- Drugs@FDA search: Semax — FDA drug database (if approved)
- PubMed search: Semax — NCBI PubMed
- PubMed Central search: Semax — NCBI PMC
Reference
No ref on file.